Oregon Public Employees Retirement Fund’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,452	Closed	-$97.9K	–	1713
2023 Q1	$97.9K	Sell	3,452 -10	-0.3%	-$297	﹤0.01%	1671
2022 Q4	$101K	Sell	3,462 -213	-6%	-$6.77K	﹤0.01%	1670
2022 Q3	$97K	Sell	3,675 -167	-4%	-$6.13K	﹤0.01%	1658
2022 Q2	$171K	Sell	3,842 -500	-12%	-$23K	﹤0.01%	1443
2022 Q1	$215K	Sell	4,342 -100	-2%	-$4.8K	﹤0.01%	1612
2021 Q4	$226K	Sell	4,442 -441	-9%	-$22.9K	﹤0.01%	1503
2021 Q3	$272K	Hold	4,883	–	–	﹤0.01%	1471
2021 Q2	$209K	Hold	4,883	–	–	﹤0.01%	1517
2021 Q1	$204K	Buy	4,883 +100	+2%	+$4.64K	﹤0.01%	1530
2020 Q4	$223K	Buy	4,783 +724	+18%	+$33.9K	﹤0.01%	1477
2020 Q3	$172K	Hold	4,059	–	–	﹤0.01%	1448
2020 Q2	$195K	Hold	4,059	–	–	﹤0.01%	1404
2020 Q1	$187K	Hold	4,059	–	–	﹤0.01%	1356
2019 Q4	$244K	Sell	4,059 -200	-5%	-$11.9K	﹤0.01%	1427
2019 Q3	$241K	Buy	4,259 +100	+2%	+$5.62K	﹤0.01%	1485
2019 Q2	$232K	Sell	4,159 -100	-2%	-$5.22K	﹤0.01%	1506
2019 Q1	$215K	Buy	4,259 +77	+2%	+$3.43K	﹤0.01%	1504
2018 Q4	$168K	Buy	+4,182	New	+$216K	﹤0.01%	1546

Other funds holding EGRX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Oregon Public Employees Retirement Fund's EGRX Position: Q2 2023 in Review

Oregon Public Employees Retirement Fund sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2023, closing a stake of 3,452 shares — an estimated $97.9K sold.

Oregon Public Employees Retirement Fund first reported a position in EGRX in Q4 2018 and held it in 18 quarters. The position peaked at $272K in Q3 2021. 126 funds tracked by Wall St. Rank hold EGRX as of Q2 2023.

Oregon Public Employees Retirement Fund reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 3,452 Eagle Pharmaceuticals, Inc. shares in Q2 2023, an estimated $97.9K.
Oregon Public Employees Retirement Fund first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2018 and held it in 18 quarters.
Oregon Public Employees Retirement Fund's Eagle Pharmaceuticals, Inc. position peaked at $272K in Q3 2021.
126 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2023.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2023, filed 26 Jul 2023.